Showing results (131-140 of 162) with videos related to
Sort By:
Pageof 17
The Journal of Infectious Diseases|February 3, 2006
Repeat-region polymorphisms in the gene for the dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin-related molecule: effects on HIV-1 susceptibilityHuanliang Liu, Mary Carrington, Chunhui Wang, et al.Journal of Virology|July 17, 2015
Critical Role for the Adenosine Pathway in Controlling Simian Immunodeficiency Virus-Related Immune Activation and Inflammation in Gut Mucosal TissuesTianyu He, Egidio Brocca-Cofano, Delbert G Gillespie, et al.Proceedings of the National Academy of Sciences of the United States of America|February 27, 2008
Epitope discovery in West Nile virus infection: Identification and immune recognition of viral epitopesCurtis P McMurtrey, Alina Lelic, Paolo Piazza, et al.Influenza and Other Respiratory Viruses|April 17, 2020
Influenza vaccine effectiveness among outpatients in the US Influenza Vaccine Effectiveness Network by study site 2011-2016Goundappa K Balasubramani, Mary Patricia Nowalk, Theresa M Sax, et al.Journal of Virology|July 20, 2012
Early HLA-B*57-restricted CD8+ T lymphocyte responses predict HIV-1 disease progressionCatherine A Brennan, F Javier Ibarrondo, Catherine A Sugar, et al.Plos Pathogens|April 21, 2017
Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activationRajesh T Gandhi, Deborah K McMahon, Ronald J Bosch, et al.Plos One|February 8, 2011
The dual impact of HIV-1 infection and aging on naïve CD4 T-cells: additive and distinct patterns of impairmentTammy M Rickabaugh, Ryan D Kilpatrick, Lance E Hultin, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|October 31, 2013
Safety, tolerability, and immunogenicity of repeated doses of dermavir, a candidate therapeutic HIV vaccine, in HIV-infected patients receiving combination antiretroviral therapy: results of the ACTG 5176 trialBenigno Rodriguez, David M Asmuth, Roy M Matining, et al.Frontiers in Immunology|June 22, 2026
Type-1 inflammatory imprinting and programmed responsiveness to CD40L enhance Siglec-1-dependent HIV-1 trans-infection by dendritic cellsE Grace Bothwell, Allison E DePuyt, Colleen R Zaccard, et al.HIV Research & Clinical Practice|November 19, 2020
COVID-19 symptoms and SARS-CoV-2 infection among people living with HIV in the US: the MACS/WIHS combined cohort studyGypsyamber D'Souza, Gayle Springer, Deborah Gustafson, et al.Pageof 17